Back to DE D. E. Shaw & Co., Inc.

ADMAADMA

Showing 8 of 23 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ADMA Biologics Inc

Yes. D. E. Shaw holds 5,274,597 shares of ADMA (ADMA Biologics), worth $44.1M, as of its Q2 2026 13F filing. It increased the position from 560,827 shares in Q1 2026. D. E. Shaw has held ADMA since Q4 2021, across 19 quarterly 13F filings.

Current Value

$44.1M

Current Shares

5.3M

Total Value Change

-$61.1M

Total Shares Change

+10,502

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.3M
+840.5%
$44.1M0.0%$8.37
47
2026-Q1
Increased
560,827
+0.7%
$5.1M0.0%$9.01
27
2025-Q4
Increased
557,153
+67.5%
$10.2M0.0%$18.24
41
2025-Q3
Decreased
332,701
-60.0%
$4.9M0.0%$14.66
0
2025-Q2
Decreased
832,563
-45.4%
$15.2M0.0%$18.21
0
2025-Q1
Decreased
1.5M
-50.3%
$30.3M0.0%$19.84
0
2024-Q4
Decreased
3.1M
-41.8%
$52.6M0.0%$17.15
0
2024-Q3
Decreased
5.3M
-22.9%
$105.2M0.1%$19.99
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used